The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Michael Hallek Executive Steering Committee Member

Michael Hallek Executive Steering Committee Member

Professor Michael Hallek is the Director of Clinic I for Internal Medicine and Associated Principle Investigator at the  University Hospital Cologne, Cologne, DE, and the Director of the  Center of Integrated Oncology (CIO) in Aachen, Bonn, Cologne, and Düsseldorf, DE.

Prof. Hallek obtained his medical degree from the  Ludwig-Maximilians-Universität München, DE, in 1985 and was a Research Associate at the  Dana Farber Cancer Institute and  Harvard Medical School, Boston, US, from 1990–1992. He became a senior consultant at the Ludwig-Maximilians-Universität München, DE, between 1995−2003. His main research focus is chronic lymphocytic leukemia.

Positions of responsibility/awards:

  • Chairman of Scientific Committee,  European School of Haematology since 2018
  • Awarded the German Cancer Award and the Arthur Burkhardt Award in 2017
  • Awarded the Walter-Siegenthaler Medal in 2016
  • Executive Chairman of the German Society of Hematology and Medical Oncology ( DGHO) since 2018
  • Scientific Board Member of the Bundesärztekammer(German Chamber of Physicians)
  • Editor-in-Chief of  Journal of Oncology Research and Treatment
  • Member of the  German National Academy of Sciences (Leopoldina)
  • Chairman of the Clinical Research Unit 286 “DNA damage response in CLL” (DFG)
  • Awarded the Binet-Rai Medal of the International Workshop on CLL (iwCLL) in 2013
  • Awarded the Paul Martini Prize in 2012
  • Scientific Committee (Core Group) iwCLL since 2000
  • Research Group Leader,  Gene Center Munich between 1994−2005

Founder and Chairman of the  German CLL Study Group since 1996

| |